Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Paoletti

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
The Journal of Infectious Diseases|October 1, 1996
Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160B Fleury, G Janvier, G Pialoux, et al.
Nature Medicine|April 1, 1995
HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaquesA G Abimiku, G Franchini, J Tartaglia, et al.
Blood|October 6, 1997
Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapyG Ferrari, C Berend, J Ottinger, et al.
The Science of the Total Environment|October 3, 2021
Chronic ozone exposure preferentially modifies root rather than foliar metabolism of date palm (Phoenix dactylifera) saplingsL Arab, Y Hoshika, H Müller, et al.
Environmental Pollution (Barking, Essex : 1987)|December 29, 2009
Advances of air pollution science: from forest decline to multiple-stress effects on forest ecosystem servicesE Paoletti, M Schaub, R Matyssek, et al.
AIDS Research and Human Retroviruses|April 9, 1999
CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacyM Leno, L Carter, D J Venzon, et al.
Virology|May 26, 1997
Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virusM Girard, E van der Ryst, F Barré-Sinoussi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKRH Park, M V Davies, J O Langland, et al.
Journal of the National Cancer Institute|March 19, 1997
Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growthM Kawakita, G S Rao, J K Ritchey, et al.
European Journal of Immunology|August 1, 1996
Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunizationC E Allsopp, M Plebanski, S Gilbert, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
The Journal of Infectious Diseases|October 1, 1996
Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160B Fleury, G Janvier, G Pialoux, et al.
Nature Medicine|April 1, 1995
HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaquesA G Abimiku, G Franchini, J Tartaglia, et al.
Blood|October 6, 1997
Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapyG Ferrari, C Berend, J Ottinger, et al.
The Science of the Total Environment|October 3, 2021
Chronic ozone exposure preferentially modifies root rather than foliar metabolism of date palm (Phoenix dactylifera) saplingsL Arab, Y Hoshika, H Müller, et al.
Environmental Pollution (Barking, Essex : 1987)|December 29, 2009
Advances of air pollution science: from forest decline to multiple-stress effects on forest ecosystem servicesE Paoletti, M Schaub, R Matyssek, et al.
AIDS Research and Human Retroviruses|April 9, 1999
CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacyM Leno, L Carter, D J Venzon, et al.
Virology|May 26, 1997
Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virusM Girard, E van der Ryst, F Barré-Sinoussi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKRH Park, M V Davies, J O Langland, et al.
Journal of the National Cancer Institute|March 19, 1997
Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growthM Kawakita, G S Rao, J K Ritchey, et al.
European Journal of Immunology|August 1, 1996
Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunizationC E Allsopp, M Plebanski, S Gilbert, et al.
Pageof 21